Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2.
Article Details
- CitationCopy to clipboard
Riddle EL, Hanson GR, Fleckenstein AE
Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2.
Eur J Pharmacol. 2007 Sep 24;571(1):25-8. doi: 10.1016/j.ejphar.2007.05.044. Epub 2007 Jun 5.
- PubMed ID
- 17618619 [ View in PubMed]
- Abstract
High-dose administration of psychostimulants traffics the vesicular monoamine transporter-2 (VMAT-2), as assessed by subcellular fractionation of rat striatal tissue. This study demonstrates that administration of low doses of amphetamine or methylphenidate differentially traffic VMAT-2 within nerve terminals, with effects similar to those observed after high-dose administration. Trafficking of vesicular glutamate, acetylcholine, or GABA transporters was not altered by high-or low-dose amphetamine or methylphenidate treatment. These data represent the first report that amphetamine redistributes VMAT-2 protein. In addition, these data demonstrate that the trafficking of VMAT-2 after amphetamine or methylphenidate is selective for monoaminergic neurons.
DrugBank Data that Cites this Article
- Drugs